These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27786403)

  • 1. Methotrexate hypersensitivity reactions in pediatrics: Evaluation and management.
    Dilley MA; Lee JP; Broyles AD
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27786403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
    Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
    J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity to tetracyclines: Skin testing, graded challenge, and desensitization regimens.
    Maciag MC; Ward SL; O'Connell AE; Broyles AD
    Ann Allergy Asthma Immunol; 2020 Jun; 124(6):589-593. PubMed ID: 32087343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.
    Wang AL; Patil SU; Long AA; Banerji A
    Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
    Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
    Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum Chemotherapy Hypersensitivity: Prevalence and Management.
    Otani IM; Wong J; Banerji A
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):663-677. PubMed ID: 28965633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
    Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
    Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin Testing in the Evaluation and Management of Carboplatin-Related Hypersensitivity Reactions.
    Lax T; Long A; Banerji A
    J Allergy Clin Immunol Pract; 2015; 3(6):856-62. PubMed ID: 26432514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study.
    Gomez R; Harter P; Lück HJ; Traut A; Kommoss S; Kandel M; du Bois A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1284-7. PubMed ID: 19823066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
    Picard M; Castells MC
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Hypersensitivity Reactions to Taxanes.
    Picard M
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):679-693. PubMed ID: 28965634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies.
    Picard M; Galvão VR
    J Allergy Clin Immunol Pract; 2017; 5(3):600-609. PubMed ID: 28110056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity Reactions to Platinum Agents and Taxanes.
    Tsao LR; Young FD; Otani IM; Castells MC
    Clin Rev Allergy Immunol; 2022 Jun; 62(3):432-448. PubMed ID: 34338975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes.
    Isabwe GAC; Garcia Neuer M; de Las Vecillas Sanchez L; Lynch DM; Marquis K; Castells M
    J Allergy Clin Immunol; 2018 Jul; 142(1):159-170.e2. PubMed ID: 29518427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Drug Hypersensitivity.
    Rukasin CRF; Norton AE; Broyles AD
    Curr Allergy Asthma Rep; 2019 Feb; 19(2):11. PubMed ID: 30793223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
    Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
    Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab Hypersensitivity: Evaluation, Desensitization, and Potential Mechanisms.
    Wong JT; Long A
    J Allergy Clin Immunol Pract; 2017; 5(6):1564-1571. PubMed ID: 29122155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions.
    Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ
    Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.